Atrial Fibrillation Drugs Market size was valued at USD 13 billion in 2018 and is expected to witness a 3% CAGR from 2021 to 2027. Atrial fibrillation is the most common persistent cardiac arrhythmia disorder worldwide. This leads to a chaotic rhythm due to the degeneration of electrical impulses that occur in the upper ventricle […]
